Bone involvement in myelofibrosis: effectiveness of bisphosphonates.
Assous
Noémie
N
Foltz
Violaine
V
Fautrel
Bruno
B
Rozenberg
Sylvie
S
Etchepare
Fabien
F
Bourgeois
Pierre
P
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000209:etiology*; D000077268:Pamidronate; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy*; D011877:Radionuclide Imaging
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate